Concepedia

William Brazelle

WB

3

Publications

115

Citations

3

H-Index

2006

Active since

Affiliations

AstraZeneca (United Kingdom)(Current)

William Brazelle is an author at AstraZeneca (United Kingdom) specializing in tumor biology, medicine, and cell biology.

Top concepts

Publications per year

2006–2010

3

Publications

3

Histone Deacetylase Inhibitors Downregulate Checkpoint Kinase 1 Expression to Induce Cell Death in Non-Small Cell Lung Cancer Cells

William Brazelle, Jenny Kreahling, Jennifer Gemmer et al. · PLoS ONE · 2010 · 68 citations · Full text

VEGF-associated tyrosine kinase inhibition increases the tumor response to single and fractionated dose radiotherapy

William Brazelle, Wenyin Shi, Dietmar W. Siemann · International Journal of Radiation Oncology*Biology*Physics · 2006 · 33 citations

, , +9

The Vascular Endothelial Growth Factor Receptor-2 Tyrosine Kinase Inhibitor Cediranib (Recentin; AZD2171) Inhibits Endothelial Cell Function and Growth of Human Renal Tumor Xenografts

Dietmar W. Siemann, William Brazelle, Juliane M. Jürgensmeier · International Journal of Radiation Oncology*Biology*Physics · 2009 · 14 citations · Full text

, , +10

Rows per page

1–3 of 3